Calliditas is a startup based in Sweden, most recent round Acquired, 1 tracked investor.
Based in Sweden, Calliditas is a startup founded in 2004. Calliditas has been acquired. Brouky records 1 investor associated with the company.
Calliditas Therapeutics is a biopharmaceutical company focused on developing treatments for rare diseases, particularly in renal and hepatic indications. The company commercializes TARPEYO® (budesonide) for IgA nephropathy and has a pipeline including setanaxib for primary biliary cholangitis and solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.